Sunday, December 5th | 1 Tevet 5782

October 26, 2021 8:57 am

Technion Biomed Engineers Assess Novel Approach to Treating Type 2 Diabetes

avatar by

A diabetes patient testing their blood sugar level. Photo: Reversing Your Diabetes Today via Wikicommons. – A novel approach to treating Type 2 diabetes is being developed at the Technion–Israel Institute of Technology in Haifa.

The disease, caused by insulin resistance and the reduction of cells’ ability to absorb sugar, is characterized by increased blood-sugar levels. Its long-term complications include heart disease, strokes, damage to the retina that can result in blindness, kidney failure and poor blood flow in the limbs that may lead to amputations.

It is currently treated by a combination of lifestyle changes, medication and insulin injections, but ultimately is associated with a 10-year reduction in life expectancy.

Ph.D. student Rita Beckerman from the Stem Cell and Tissue Engineering Laboratory in the Technion’s Faculty of Biomedical Engineering, who conducted the research with professor Shulamit Levenberg, presented a novel treatment approach, using an autograft of muscle cells engineered to take in sugar at increased rates. Mice treated in this manner displayed normal blood sugar levels for months after a single procedure.

Related coverage

December 5, 2021 9:45 am

‘We Need to Normalize Having Women in Tech Management Positions,’ Say Israeli Executives

CTech – Should the percentage of women employees in tech be artificially inflated, or should the hiring process only be...

Share this Story: Share On Facebook Share On Twitter

Let your voice be heard!

Join the Algemeiner

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.